Almasan AG
  • Landing
  • Home
  • About
  • Portfolio
  • Services
  • Insights
  • Contact
  • Cookie Policy (EU)
Select Page

How do German hospitals live with DRGs? The German G-DRG system, background and experiences from the perspective of service providers

by Aleksandar Ruzicic | Feb 1, 2024 | Healthcare

The introduction of Diagnosis-Related Groups (DRGs) requires a thorough review and adjustment of organizational structures and processes within hospitals. Hospitals need to create conditions that enable a successful positioning on the market under DRG conditions, such...

Marketing Masterclass: Salesforce Effectiveness: Is the Pharmaceutical Industry going in the Right Direction?

by Aleksandar Ruzicic | Jan 29, 2024 | Commercial Effectiveness

As the healthcare environment for the pharmaceutical industry is undergoing major changes, salesforce effectiveness replaces the traditional ‘size sells paradigm’. Consequently, pharmaceutical companies are being forced to optimise both their bottom and top line. This...

Is procurement in Swiss hospitals professional?

by Aleksandar Ruzicic | Jan 26, 2024 | Healthcare

In the future, hospital procurement experts expect purchasing to become even more professional: from databases with up to 50 reference products to e-procurement and electronic invoicing and thus a seamless procurement system. This increases the transparency of...

The European pharmaceutical industry: Delivering sales excellence in turbulent times

by Aleksandar Ruzicic | Jan 19, 2024 | Commercial Effectiveness

As pressure on pharmaceutical companies’ margins continues to grow, the industry will be forced to explore new, more cost-effective promotional channels for physicians (such as direct mailing and e-detailing). This will require systematic ROI measurement if the...

Delivering integrated discovery informatics strategies

by Aleksandar Ruzicic | Jan 18, 2024 | R&D and Innovation Management

What is the focus of Global BioPharma Consulting? Aleks: Our clients are the biotechnology companies that use recombinant genetic engineering to develop products and the biopharmas that are using biology and chemistry together to develop products for human...
« Older Entries
Next Entries »
    Website built by The Free Website Guys🚀
    Manage Cookie Consent
    To provide the best experiences, we use technologies like cookies to store and/or access device information. Consenting to these technologies will allow us to process data such as browsing behavior or unique IDs on this site. Not consenting or withdrawing consent, may adversely affect certain features and functions.
    Functional Always active
    The technical storage or access is strictly necessary for the legitimate purpose of enabling the use of a specific service explicitly requested by the subscriber or user, or for the sole purpose of carrying out the transmission of a communication over an electronic communications network.
    Preferences
    The technical storage or access is necessary for the legitimate purpose of storing preferences that are not requested by the subscriber or user.
    Statistics
    The technical storage or access that is used exclusively for statistical purposes. The technical storage or access that is used exclusively for anonymous statistical purposes. Without a subpoena, voluntary compliance on the part of your Internet Service Provider, or additional records from a third party, information stored or retrieved for this purpose alone cannot usually be used to identify you.
    Marketing
    The technical storage or access is required to create user profiles to send advertising, or to track the user on a website or across several websites for similar marketing purposes.
    • Manage options
    • Manage services
    • Manage {vendor_count} vendors
    • Read more about these purposes
    View preferences
    • {title}
    • {title}
    • {title}